Health technology company myTomorrows has secured $29 million in funding to develop its AI-driven global platform, aiming to bring patients access to innovative therapies.  The company aims to develop a platform to bridge the gap between scientific advancement and patient access to pre-approval treatments. This includes drug candidates undergoing clinical trials or expanded access programmes […]